PPARA and obesity due to melanocortin 4 receptor deficiency: In spite of the relative weak expression level of Pparα in white adipose tissue (WAT, mainly in adipocytes and not in stromal-vascular cells), several lines of evidence support the notion that PPARα and PPARα agonists could play a functional role in the control of obesity-induced chronic inflammatory response in vivo.